申请人:Nektar Therapeutics
公开号:US20160194294A1
公开(公告)日:2016-07-07
The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
本发明涉及(除其他事项外)治疗方法,包括给予含寡聚物的取代芳基三嗪化合物。本发明的化合物,无论通过哪种给药途径给予,都比缺乏寡聚物的对应化合物表现出一种或多种优点。